CHILDREN'S PLACE INC/THE (PLCE)

US1689051076 - Common Stock

10.26  -0.15 (-1.44%)

After market: 10.2897 +0.03 (+0.29%)

Fundamental Rating

1

PLCE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 119 industry peers in the Specialty Retail industry. Both the profitability and financial health of PLCE have multiple concerns. PLCE has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year PLCE has reported negative net income.
PLCE had a negative operating cash flow in the past year.
In multiple years PLCE reported negative net income over the last 5 years.
In multiple years PLCE reported negative operating cash flow during the last 5 years.

1.2 Ratios

PLCE's Return On Assets of -20.10% is on the low side compared to the rest of the industry. PLCE is outperformed by 83.62% of its industry peers.
Industry RankSector Rank
ROA -20.1%
ROE N/A
ROIC N/A
ROA(3y)-0.46%
ROA(5y)-1.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PLCE has a worse Gross Margin (30.84%) than 62.07% of its industry peers.
PLCE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for PLCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.71%
GM growth 5Y-4.66%

0

2. Health

2.1 Basic Checks

PLCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PLCE has been increased compared to 1 year ago.
PLCE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PLCE has a worse debt to assets ratio.

2.2 Solvency

PLCE has an Altman-Z score of 1.34. This is a bad value and indicates that PLCE is not financially healthy and even has some risk of bankruptcy.
PLCE's Altman-Z score of 1.34 is on the low side compared to the rest of the industry. PLCE is outperformed by 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACCN/A
WACC10.15%

2.3 Liquidity

A Current Ratio of 0.93 indicates that PLCE may have some problems paying its short term obligations.
The Current ratio of PLCE (0.93) is worse than 80.17% of its industry peers.
PLCE has a Quick Ratio of 0.93. This is a bad value and indicates that PLCE is not financially healthy enough and could expect problems in meeting its short term obligations.
PLCE has a worse Quick ratio (0.17) than 89.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.17

1

3. Growth

3.1 Past

PLCE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2078.95%.
PLCE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.65%.
Measured over the past years, PLCE shows a decrease in Revenue. The Revenue has been decreasing by -3.73% on average per year.
EPS 1Y (TTM)-2078.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48.56%
Revenue 1Y (TTM)-10.65%
Revenue growth 3Y1.72%
Revenue growth 5Y-3.73%
Sales Q2Q%-18.75%

3.2 Future

PLCE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.25% yearly.
The Revenue is expected to decrease by -5.66% on average over the next years.
EPS Next Y117.62%
EPS Next 2Y50.96%
EPS Next 3Y32.25%
EPS Next 5YN/A
Revenue Next Year-15.44%
Revenue Next 2Y-8.47%
Revenue Next 3Y-5.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

PLCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 4.44, the valuation of PLCE can be described as very cheap.
Based on the Price/Forward Earnings ratio, PLCE is valued cheaply inside the industry as 99.14% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of PLCE to the average of the S&P500 Index (23.53), we can say PLCE is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.44

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PLCE is valued a bit cheaper than the industry average as 78.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PLCE's earnings are expected to grow with 32.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.96%
EPS Next 3Y32.25%

0

5. Dividend

5.1 Amount

No dividends for PLCE!.
Industry RankSector Rank
Dividend Yield N/A

CHILDREN'S PLACE INC/THE

NASDAQ:PLCE (1/14/2025, 8:00:01 PM)

After market: 10.2897 +0.03 (+0.29%)

10.26

-0.15 (-1.44%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-25 2024-11-25/amc
Earnings (Next)N/A N/A
Inst Owners83.52%
Inst Owner Change-0.06%
Ins Owners0.73%
Ins Owner Change4.91%
Market Cap131.12M
Analysts45.71
Price Target15.3 (49.12%)
Short Float %26.19%
Short Ratio7.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.89%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)-4.27%
Revenue beat(4)0
Avg Revenue beat(4)-7.48%
Min Revenue beat(4)-13.26%
Max Revenue beat(4)-2.88%
Revenue beat(8)1
Avg Revenue beat(8)-4.79%
Revenue beat(12)1
Avg Revenue beat(12)-4.97%
Revenue beat(16)3
Avg Revenue beat(16)-2.54%
PT rev (1m)-11.76%
PT rev (3m)-16.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)295%
EPS NY rev (1m)-30.58%
EPS NY rev (3m)508.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.87%
Revenue NY rev (1m)-5.2%
Revenue NY rev (3m)-6.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.44
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.25
EPS(TTM)-8.28
EYN/A
EPS(NY)2.31
Fwd EY22.52%
FCF(TTM)-9.59
FCFYN/A
OCF(TTM)-8.1
OCFYN/A
SpS112.11
BVpS-3.88
TBVpS-4.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.1%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.84%
FCFM N/A
ROA(3y)-0.46%
ROA(5y)-1.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.71%
GM growth 5Y-4.66%
F-Score4
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 13.16
Cap/Depr 45.45%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.17
Altman-Z 1.34
F-Score4
WACC10.15%
ROIC/WACCN/A
Cap/Depr(3y)65.71%
Cap/Depr(5y)84.6%
Cap/Sales(3y)1.97%
Cap/Sales(5y)3.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2078.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48.56%
EPS Next Y117.62%
EPS Next 2Y50.96%
EPS Next 3Y32.25%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.65%
Revenue growth 3Y1.72%
Revenue growth 5Y-3.73%
Sales Q2Q%-18.75%
Revenue Next Year-15.44%
Revenue Next 2Y-8.47%
Revenue Next 3Y-5.66%
Revenue Next 5YN/A
EBIT growth 1Y97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year704.83%
EBIT Next 3Y108.79%
EBIT Next 5YN/A
FCF growth 1Y-1278.83%
FCF growth 3YN/A
FCF growth 5Y-1.06%
OCF growth 1Y-311.62%
OCF growth 3YN/A
OCF growth 5Y-7.88%